{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:38:11Z","timestamp":1768624691112,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clinbiochem.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T22:23:13Z","timestamp":1614637393000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines"],"prefix":"10.1016","volume":"92","author":[{"given":"Luis J.","family":"Morales-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda S.","family":"Pacheco-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.02.008_b0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/leu.2008.131","article-title":"Pathogenesis and treatment of renal failure in multiple myeloma","volume":"22","author":"Dimopoulos","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/2040620712466863","article-title":"Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions","volume":"4","author":"Tosi","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0015","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0020","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0025","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0030","doi-asserted-by":"crossref","unstructured":"S.V. Rajkumar, J.-L. Harousseau, B. Durie, K.C. Anderson, M. Dimopoulos, R. Kyle, J. Blade, P. Richardson, R. Orlowski, D. Siegel, S. Jagannath, T. Facon, H. Avet-Loiseau, S. Lonial, A. Palumbo, J. Zonder, H. Ludwig, D. Vesole, O. Sezer, N.C. Munshi, J. San Miguel, International Myeloma Workshop Consensus Panel 1, Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1, Blood. 117 (2011) 4691\u20134695. DOI:10.1182\/blood-2010-10-299487.","DOI":"10.1182\/blood-2010-10-299487"},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/CCLM.2010.012","article-title":"Analytical performance of the serum free light chain assay","volume":"48","author":"Briand","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/647238","article-title":"Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy","volume":"2014","author":"Kim","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.clinbiochem.2012.12.015","article-title":"Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser","volume":"46","author":"Maisin","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clinbiochem.2017.05.009","article-title":"Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPAPlus","volume":"51","author":"White-Al Habeeb","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0004563212473447","article-title":"A multicentre study comparing two methods for serum free light chain analysis","volume":"50","author":"Lock","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0065","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2011.624","article-title":"N Latex FLC \u2013 new monoclonal high-performance assays for the determination of free light chain kappa and lambda","volume":"49","author":"te Velthuis","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0070","doi-asserted-by":"crossref","DOI":"10.1515\/cclm.2011.793","article-title":"Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis","volume":"50","author":"Hoedemakers","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0075","article-title":"Analytical and clinical concordance of free light chain assay","volume":"13","author":"Smith","year":"2019","journal-title":"Pract. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0080","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1515\/cclm-2018-0040","article-title":"Reference ranges of the Sebia free light chain ratio in patients with chronic kidney disease","volume":"56","author":"Lutteri","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1515\/cclm-2017-0339","article-title":"Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods","volume":"56","author":"Jacobs","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2018.09.030","article-title":"Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument","volume":"487","author":"Lutteri","year":"2018","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0095","article-title":"Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum \u03ba and \u03bb immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool","volume":"55","author":"Campbell","year":"2017","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0105","unstructured":"Clinical and Laboratory Standards Institute, User verification of precision and estimation of bias: approved guideline EP15-A3, 3rd ed., CLSI, 2014."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0110","unstructured":"Clinical and Laboratory Standards Institute, Defining, establishing and verifying reference intervals in the clinical laboratory: approved guideline EP28-A3C, 3rd ed., CLSI, 2010."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinbiochem.2018.06.003","article-title":"Reference intervals and diagnostic ranges for serum free \u03ba and free \u03bb immunoglobulin light chains vary by instrument platform: implications for classification of patient results in a multi-center study","volume":"58","author":"Cotten","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jalm.2019.029330","article-title":"Serum free light chain assay: shift toward a higher \u03ba\/\u03bb ratio","volume":"5","author":"Rindlisbacher","year":"2020","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0125","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/jalm\/jfaa093","article-title":"Free light chain assay drift: potential for misdiagnosis?","volume":"5","author":"Murray","year":"2020","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0130","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41375-018-0041-0","article-title":"Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used","volume":"32","author":"Bossuyt","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0135","first-page":"P-418a","article-title":"Age dependancy of reference values of immunoglobulin heavy\/light chain pairs and free light chains serum levels","volume":"13","author":"Machalkova","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0140","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinbiochem.2013.01.014","article-title":"Serum free light chain reference values: a critical approach","volume":"46","author":"Altinier","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0145","first-page":"2605","article-title":"Robust reference intervals for serum kappa and lambda free light chains from a multi centre study population from Hyderabad, India: myeloma diagnostic implications","volume":"17","author":"Mohammed","year":"2016","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1258\/acb.2012.011264","article-title":"Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots","volume":"49","author":"Pretorius","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.113","article-title":"Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease","volume":"2","author":"Yang","year":"2019","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0160","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1515\/cclm-2015-1068","article-title":"Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents","volume":"54","author":"Carr-Smith","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41408-019-0267-8","article-title":"Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma","volume":"10","author":"Schieferdecker","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0170","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1515\/cclm-2018-1369","article-title":"Prognostic value of involved\/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients","volume":"57","author":"Henriot","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0175","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/j.clml.2019.01.007","article-title":"Comparison of sebia free light chain assay with freelite assay for the clinical management of diagnosis, response, and relapse assessment in multiple myeloma","volume":"19","author":"Caillon","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.02.008_b0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clml.2018.03.005","article-title":"Serum free light chain difference and \u03b22 microglobulin levels are risk factors for thromboembolic events in patients with AL amyloidosis","volume":"18","author":"Park","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12882-017-0661-z","article-title":"Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test","volume":"18","author":"Heaney","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fimmu.2020.00319","article-title":"Serum free light chains in common variable immunodeficiency disorders: role in differential diagnosis and association with clinical phenotype","volume":"11","author":"Scarpa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10875-018-0478-y","article-title":"Serum free light chains in CVID-a marker for differential diagnosis","volume":"38","author":"Hanitsch","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.02.008_b0200","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3389\/fimmu.2020.02004","article-title":"Serum free immunoglobulins light chains: a common feature of common variable immunodeficiency?","volume":"11","author":"Guevara-Hoyer","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:57:09Z","timestamp":1757865429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":40,"alternative-id":["S0009912021000540"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.02.008","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}